These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1837979)

  • 41. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
    Fujihira T; Kanematsu S; Umino A; Yamamoto N; Nishikawa T
    Neurochem Int; 2007; 51(2-4):233-6. PubMed ID: 17662507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. d-Cycloserine enhances implicit memory in Alzheimer patients.
    Schwartz BL; Hashtroudi S; Herting RL; Schwartz P; Deutsch SI
    Neurology; 1996 Feb; 46(2):420-4. PubMed ID: 8614505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity.
    Goff DC
    Curr Neuropharmacol; 2017; 15(1):21-34. PubMed ID: 26915421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role beyond learning for NMDA receptors in reward-based decision-making-a pharmacological study using d-cycloserine.
    Scholl J; Günthner J; Kolling N; Favaron E; Rushworth MF; Harmer CJ; Reinecke A
    Neuropsychopharmacology; 2014 Nov; 39(12):2900-9. PubMed ID: 24924800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis.
    Ingram DK; Spangler EL; Iijima S; Ikari H; Kuo H; Greig NH; London ED
    Life Sci; 1994; 55(25-26):2037-49. PubMed ID: 7997063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Therapeutic Role of d-Cycloserine in Schizophrenia.
    Goff D
    Adv Pharmacol; 2016; 76():39-66. PubMed ID: 27288073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.
    Khan MA; Houck DR; Gross AL; Zhang XL; Cearley C; Madsen TM; Kroes RA; Stanton PK; Burgdorf J; Moskal JR
    Int J Neuropsychopharmacol; 2018 Mar; 21(3):242-254. PubMed ID: 29099938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum.
    Khakpai F; Nasehi M; Haeri-Rohani A; Eidi A; Zarrindast MR
    Behav Brain Res; 2012 May; 231(1):1-10. PubMed ID: 22421366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats.
    Andersen JM; Lindberg V; Myhrer T
    Behav Brain Res; 2002 Feb; 129(1-2):211-6. PubMed ID: 11809513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulatory effects of an NMDAR partial agonist in MK-801-induced memory impairment.
    Vishnoi S; Raisuddin S; Parvez S
    Neuroscience; 2015 Dec; 311():22-33. PubMed ID: 26454025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects on delayed non-matching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine or NMDA receptor antagonist MK-801 into the dorsal or ventral extent of the hippocampus.
    Robinson JK; Mao JB
    Brain Res; 1997 Aug; 765(1):51-60. PubMed ID: 9310393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The NMDA receptor partial agonist d-cycloserine does not enhance motor learning.
    Günthner J; Scholl J; Favaron E; Harmer CJ; Johansen-Berg H; Reinecke A
    J Psychopharmacol; 2016 Oct; 30(10):994-9. PubMed ID: 27436230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D-Cycloserine enhances spatial memory in spontaneous place recognition in rats.
    Ozawa T; Kumeji M; Yamada K; Ichitani Y
    Neurosci Lett; 2012 Feb; 509(1):13-6. PubMed ID: 22215115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. D-Cycloserine enhances conditioned taste aversion learning in rats.
    Nunnink M; Davenport RA; Ortega B; Houpt TA
    Pharmacol Biochem Behav; 2007; 87(3):321-30. PubMed ID: 17561237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: influence of d-cycloserine.
    Ortiz V; Giachero M; Espejo PJ; Molina VA; Martijena ID
    Int J Neuropsychopharmacol; 2015 Jan; 18(4):. PubMed ID: 25617327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Scopolamine effects on memory retention in mice: a model of dementia?
    Flood JF; Cherkin A
    Behav Neural Biol; 1986 Mar; 45(2):169-84. PubMed ID: 3964171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine.
    Liraz-Zaltsman S; Yaka R; Shabashov D; Shohami E; Biegon A
    J Mol Neurosci; 2016 Sep; 60(1):46-62. PubMed ID: 27421842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze.
    Pussinen R; Sirviö J
    J Psychopharmacol; 1999; 13(2):171-9. PubMed ID: 10475724
    [TBL] [Abstract][Full Text] [Related]  

  • 59. D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain.
    Chessell IP; Procter AW; Francis PT; Bowen DM
    Brain Res; 1991 Nov; 565(2):345-8. PubMed ID: 1842701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interaction of N-methyl-D-aspartate and Dopamine D1 receptors in modulation of passive avoidance extinction at mice with depressive-like state].
    Dubrovina NI; Zinov'eva DV
    Ross Fiziol Zh Im I M Sechenova; 2011 Jul; 97(7):700-7. PubMed ID: 21961294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.